SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration
SOPHiA GENETICS SA - Ordinary Shares (SOPH)
Company Research
Source: PR Newswire
New Multimodal Algorithm Highlights Predictive Benefit Of Artificial Intelligence (AI) for Cancer ResearchBOSTON and ROLLE, Switzerland, March 15, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, and the French Kidney Cancer Research Network (UroCCR) collaborated on a study using a multimodal algorithm to help predict post-operative outcomes for those facing renal cell carcinoma (RCC), with the results recently published in npj Precision Oncology. The findings of the study showed the artificial intelligence (AI) model co-constructed by SOPHiA GENETICS and UroCCR provided a strong prediction for post-operative outcomes when compared to usual prognostic scores. This publication follows a prior collaboration that demonstrated the value of multimodal analysis on pre-operative kidney cancer upstaging.UroCCR is one of the world's largest collaborative kidney cancer networks with 51 multidisciplinary clinical teams acr
Show less
Read more
Impact Snapshot
Event Time:
SOPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SOPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SOPH alerts
High impacting SOPHiA GENETICS SA - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
SOPH
News
- SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024 [Yahoo! Finance]Yahoo! Finance
- SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024GlobeNewswire
- SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa [Yahoo! Finance]Yahoo! Finance
- SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in AfricaPR Newswire
- We Think SOPHiA GENETICS (NASDAQ:SOPH) Can Afford To Drive Business Growth [Yahoo! Finance]Yahoo! Finance
SOPH
Earnings
- 3/5/24 - Miss
SOPH
Sec Filings
- 4/19/24 - Form 144
- 4/19/24 - Form 144
- 4/19/24 - Form 144
- SOPH's page on the SEC website